Immunic

Immunic is a clinical-stage biopharmaceutical company developing selective oral immunology therapies for chronic inflammatory and autoimmune diseases. 

Alzheimers brain
Biotech

Immunic's investors appeased by biomarker data from MS trial

Immunic’s decision to narrow its focus appears to be paying off, with investors reacting well to biomarker data from its multiple sclerosis candidate
James Waldron Oct 10, 2023 9:35am
change direction new plan alter arrows move reprioritize

Immunic punts psoriasis and prostate programs to narrow focus

Apr 5, 2023 9:05am
Nasdaq

Dreaded 'high placebo rate' hits Immunic's psoriasis trial

Oct 21, 2022 8:00am
money and shares declining

Immunic regains some momentum with multiple sclerosis update

Jun 15, 2022 9:35am
stock market down crash fail shares

Immunic shifts back to multiple sclerosis after UC fail

Jun 6, 2022 6:45am